Objective: Depression is an established risk factor for acute coronary syndrome (ACS), with an impact on cardiac prognosis; nonetheless, the literature disagrees on the role played by anxiety. No study has evaluated this relationship in a cardiac population with no history of depression and after their first diagnosis of ACS. The aim of this study is to explore these associations without the confounding role of long-lasting heart disease or psychiatric illnesses. Method: Two hundred sixty-six patients with no history of depression completed the Hospital Anxiety and Depression Scale and the Primary Care Evaluation of Mental Disorder at baseline and at 1, 2, 4, 6, 9, 12, and 24 months follow-up after their first diagnosis of ACS. During the follow-up period, we collected information regarding the major adverse cardiac events. Results: Developing a first-ever depressive episode, in a proportional hazard model, was associated with almost 3 times the risk of a recurrent cardiac event (odds ratio ϭ 2.590, 95% confidence interval [CI] [1.321, 5.078], p ϭ .006). Furthermore, a moderation analysis revealed that increasing levels of baseline anxiety had opposing effects on cardiac outcomes, being protective only in those who did not develop incident depression (B ϭ Ϫ0.0824, 95% CI [Ϫ0.164, Ϫ0.005], p ϭ .048). No dose-response effect between depressive or anxious symptoms and cardiac outcomes emerged. Conclusion: Our results confirm the detrimental effect of depression on cardiac prognosis in a selected population and suggest that anxiety after the first diagnosis of ACS might have different roles depending on the illness' course.
The detrimental effect of mental illnesses (Correll et al., 2017) -and, specifically, depression-on cardiac outcome is wellestablished (Burg et al., 2013; Carney et al., 2003; Geulayov, Novikov, Dankner, & Dankner, 2018; Meijer et al., 2013; Nicholson, Kuper, & Hemingway, 2006) . It remains unclear (Carney & Freedland, 2012) as to what extent first-time incident depression-defined here as the first episode of depression-occurring after the onset of coronary disease in never-depressed people is particularly cardiotoxic (Goodman, Shimbo, Haas, Davidson, & Rieckmann, 2008; Meyer, Hussein, Lange, & Herrmann-Lingen, 2014; Osler et al., 2016; Surtees et al., 2008) or whether a dose-response relationship between the depressive symptoms and cardiac outcome exists (Smolderen, Buchanan, et al., 2017) .
It is possible that the studies supporting the latter hypothesis are biased by the effect of long-lasting depressive and cardiac illnesses (Lespérance, Frasure-Smith, Talajic, & Bourassa, 2002; Stenman, Holzmann, & Sartipy, 2016) . For example, evaluating subjects in the early stages of coronary disease, a recent study failed to find a correlation between depression and acute coronary syndrome (ACS) severity (Pelletier et al., 2014) , whereas another (Yammine, Frazier, Padhye, Sanner, & Burg, 2017) found that only previous, but not current, depressive symptoms predict subsequent major cardiac events.
Similarly, the role played by anxiety is still debated (Sokoreli, de Vries, Pauws, & Steyerberg, 2016; Tully, Harrison, Cheung, & Cosh, 2016) . Some authors suggest that it increases the risk of adverse cardiac outcomes (de Jager et al., 2018; Van Beek et al., 2016) , others have found that it exerts a protective effect on new cardiac events (Meyer, Hussein, Lange, & Herrmann-Lingen, 2015) , and yet another study (Geulayov et al., 2018) did not find any effect on mortality.
The aim of this study is to evaluate the role of incident depression in predicting recurrent cardiac events, within 2 years after the first diagnosis of ACS, in a population of never-depressed subjects. This allows excluding the role of long-lasting illnesses and being more precise in defining a dose-response relationship between depression and cardiac outcome. We further try to clarify the role played by anxiety in predicting recurrent cardiac events by exploring the interaction between anxious and depressive symptoms measured repeatedly over the follow-up period.
Method Participants
Patients consecutively admitted to the Coronary Intensive Care Unit of Parma from January 2009 to March 2012 for a first-ever diagnosis of ACS were included in the study. The study was fully explained and all participants provided informed consent. The local ethics committee (Comitato Etico per Parma) approved the study protocol, which was conducted according to the Declaration of Helsinki (World Medical Association, 2013) . Subjects were included in the study if (a) they presented symptoms suggestive of an acute coronary syndrome and for the first time: an ST-segment elevation myocardial infarction (STEMI); a non-ST-segment elevation myocardial infarction (NSTEMI); or unstable angina (Hamm et al., 2011; Van De Werf et al., 2008) . The working diagnosis of NSTE-ACS was a rule-out diagnosis based on the Electrocardiography (ECG). Biomarkers (troponins) further distinguished NSTEMI and unstable angina (Hamm et al., 2011) ; (b) they had no history of major depression; (c) they did not satisfy the criteria for major depression at baseline; (d) they were over 18 years old; (e) they were proficient in the Italian language; (f) they had no substance abuse or other dependencies; (g) they showed no cognitive impairment as demonstrated by a Mini Mental State Examination (Folstein, Folstein, & McHugh, 1975) lower than 25; and (h) they did not take any psychotropic medications.
Subjects who did not complete all the evaluation or withdrew (n ϭ 111) were excluded from the analyses. No difference in any of the sociodemographic variables emerged between the completers (n ϭ 266) and those who dropped out.
Data Collection
At enrollment for each patient, a Global Registry of Acute Coronary Events (GRACE) score, which assesses mortality risk after acute coronary events (Eagle et al., 2004) , was calculated. The GRACE score considers age, history of myocardial infarction, past or current congestive heart failure (CHF), heart rate, systolic blood pressure, serum creatinine, elevated cardiac enzymes, STsegment depression on ECG at admission, and in hospital percutaneous intervention.
Within 3 days of the acute coronary syndrome, sociodemographic variables were collected. All the subjects completed (a) the Primary Care Evaluation of Mental Disorder (PRIME-MD) to diagnose current or previous depressive episodes (Spitzer et al., 1994) , followed by a psychiatric interview to confirm the diagnosis of a previous and current depressive episode, and (b) the Hospital Anxiety and Depression Scale (HADS; Costantini et al., 1999; Zigmond & Snaith, 1983) .
Sociodemographic variables included gender, age, education (i.e., primary school from the ages of 5 to 10, secondary school from ages 11 to 14, high school from ages 15 to 19, and university for any graduated degree), marital status, and working status (dichotomized into employed and unemployed; the latter including both students and retired). All subjects completed a form on which we asked height, weight, alcohol consumption, and whether they were smokers; we estimated the mean number of cigarettes smoked in a day.
The PRIME-MD is a structured interview, as opposed to the self-administered tool ), designed to diagnose mental disorders according to the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; American Psychiatric Association). The PRIME-MD evaluates the presence of nine depressive symptoms in the previous 2 weeks. Each symptom is rated on a 4-point scale (from not at all to most days). The PRIME-MD has shown good specificity and sensitivity in detecting major depression in primary care (Spitzer, Kroenke, Williams, & Patient Health Questionnaire Primary Care Study Group, 1999) . A clinician-administered questionnaire would increase the specificity, given that the predictive value of selfadministered questionnaires is generally low (Bunevicius, Staniute, Brozaitiene, & Bunevicius, 2012) .
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disorders (Dunbar, Ford, Hunt, & Der, 2000) . As a result of this, the baseline anxiety seems to reflect general distress (Norton, Cosco, Doyle, Done, & Sacker, 2013) . After inclusion in the study, patients were reevaluated with the same questionnaires (i.e., HADS and PRIME-MD) 1, 2, 4, 6, 9, 12, and 24 months later. At each interval, the PRIME-MD was followed by a short interview performed by a psychiatrist, who verified if the answers were appropriate to the patients' condition. A patient was defined as nondepressed if he or she did not satisfy the criteria (American Psychiatric Association, 2000) for major or minor depression at any evaluation during the follow-up period.
Information regarding the recurrent major adverse cardiovascular event (MACE) over the follow-up period was collected by the Coronary Intensive Care Unit Information Technology registry and matched by phone calls to the participants in case the cardiac event was treated outside of the catchment area. MACE included (Panchal et al., 2014) recurrence of ACS, nonelective revascularization, acute hospitalization because of postischemic heart failure, or any death unless an unequivocal noncardiac cause could be established (Van Beek et al., 2016) . Nonelective revascularizations during hospital admissions with other MACE diagnoses were not counted separately. We considered only spontaneous myocardial infarction rather than both spontaneous infarction and periprocedural infarction (Patti et al., 2011) . Compared with the standard definition of MACE, we excluded all-cause mortality and strokes, as predictors might differ among these groups (Moise et al., 2018) .
Statistical Analyses
MACEs occur in 15% of subjects in the 2 years after an acute coronary syndrome (Yammine et al., 2017) , and depression occurs in up to 20% of them (Thombs et al., 2006) . We therefore estimated an initial population of 400 subjects, so that, with a dropout rate of 10% per year in a cardiac population (Worcester, Murphy, Mee, Roberts, & Goble, 2004) , would have resulted in approximately 300 subjects at follow-up with 45 MACE and 60 depressive episodes. This would be enough to run a regression analysis with up to four predictors, as suggested by the study design (i.e., age, gender, and depressive and anxious symptoms).
For anxiety and depression, we calculated the areas under the curve (AUC A and AUC D , respectively) with the trapezoid method and with the HADS Anxiety and Depression subscales.
The rate of patients classified as with or without a recurrent MACE over the course of the follow-up was calculated. A proportional hazard model (Cox regression, using the 'enter' method) was used to evaluate which sociodemographic and clinical variables predicted the development of a MACE during the follow-up period. In the first block of the model, we entered the age, which differed between the two groups (i.e., MACE vs. no-MACE), and the GRACE score, which is a validated predictor of outcome. In the second block, we added the HADS scores at baseline (both the Anxiety and Depression subscales) as a measure of general distress or a transient reaction. In the third block, the amount of This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
anxiety and depression were entered as two separate AUCs at HADS in order to evaluate the dose-response relationship. Lastly, we entered the development of a first-ever incident depressive episode as an independent variable in the fourth block. Significant multiplicative interactions between two independent variables resulting in the above additive model were further explored in moderation analyses (SPSS PROCESS macro, Model #1; Hayes, 2013) . Collinearity among the parameters was explored. To compare the course of depression and anxiety over the follow-up period, we performed a repeated measures ANOVA, with groups (depressed vs. nondepressed; with vs. without MACE) as betweensubjects factors.
Results
Two hundred sixty-six subjects completed all evaluations in the second year after their first diagnosis of ACS. At baseline, 304 subjects completed all questionnaires. Data from the same sample, or part of it (i.e., completers at 1-year follow-up), were published in previous articles aimed at evaluating risk factors for the development of an incident depressive disorder (Marchesi et al., 2014a (Marchesi et al., , 2014b Ossola, Paglia, et al., 2015) . The patients flowchart is detailed in Figure 1 .
Throughout the follow-up period, 69 (22.7%) patients developed an incident depressive episode (Table 1) . During the 2 years of follow-up, 57 subjects (21.4%) developed at least one recurrent MACE. Among these, 15 (4.9%) were deaths. The only difference observed between patients with or without a recurrent MACE was age: Patients who developed a MACE were slightly older (d ϭ .45; Table 2 ). The onset of the depressive episode was not preceded by a new cardiac event in any of the included subjects.
The development of a depressive episode during the follow-up period (t ϭ 0.740, 2 ϭ 5.465, Hazard Ratio [HR] ϭ 2.449, 95% CI [1.26, 4.75] , p ϭ .008) was the only significant predictor of a recurrent MACE (Table 3) .
In our sample, baseline anxiety itself did not predict a recurrent MACE; however, we found a significant interaction (HR ϭ 1.081, 95% CI [1.021, 1.143], p ϭ .007) between incident depression and baseline HADS anxiety in predicting recurrent cardiac events. Specifically, controlling for age, gender, and GRACE score, the effect of baseline anxiety on recurrent MACE was moderated by incident depression. According our model, baseline anxiety exerted a protective effect in those who did not develop a depressive episode (B ϭ Ϫ0.0824, 95% CI [Ϫ0.164, Ϫ0.005], p ϭ .048), whereas it increased, even though not significantly, the risk of a MACE in those who developed incident depression (B ϭ 0.077, 95% CI [Ϫ0.05, 0.213], p ϭ .26).
Is it possible that in nondepressed subjects, the protective effect of baseline anxiety on the recurrent MACE was explained by the lowering of its severity over the follow-up. Entering the HADS-A scores of the nondepressed subjects (n ϭ 197) in a repeated measure ANOVA (Greenhouse-Geisser corrected, ε ϭ .44), with Note. 2 (df) ϭ 1 and t test (df) ϭ 264 if not otherwise specified. MACE ϭ major adverse cardiovascular event; GRACE ϭ Global Registry of Acute Coronary Events; BMI ϭ body mass index; HADS ϭ Hospital Anxiety and Depression Scale; AUC ϭ area under the curve. ‫ء‬ p Ͻ .05.
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time (the eight evaluations during the follow-up) and group (with and without MACE), revealed an effect of time, F(3.17, 595.99) ϭ 4.6, p ϭ .03, but no interaction between time and group, F(3.17, 595.99) ϭ 1.2, p ϭ .27. This suggests that, in nondepressed patients both with or without recurrent MACE, the levels of anxiety decreased over time but remained higher in subjects without a MACE throughout the follow-up period (Figure 2 ). Therefore, the protective effect of baseline anxiety is not explained by a different course of anxious symptoms over the follow-up period. In fact, those incidence who did develop a recurrent MACE were not more anxious during the follow-up compared to those who did not developed a new cardiac event.
Discussion
This study evaluated, in a sample of never-depressed patients experiencing their first ACS, the risk factors for the development of recurrent MACE within the 2 successive years following the first ACS.
Considering other clinical variables (i.e., baseline and cumulative scores for depression and anxiety), only age and incident depression were risk factors for the development of MACE, agreeing with the suggestion that incident depression (Keegan, Conroy, & Doyle, 2016; May et al., 2017) has a cardiotoxic effect, particularly in the year following an ACS incidence (Osler et al., 2016) . We did not find a dose-response relationship (Brunner et al., 2014) .
In suggesting a different approach for assessing the effect of anxiety in coronary patients (Sokoreli et al., 2016) , our results point out a possible interaction with depression. It is possible that increasing levels of baseline anxiety have a protective effect on cardiac outcome only in those who did not develop an incident depressive episode because of related healthy behaviors. Increased levels of anxiety may reflect the worry after the first diagnosis of ACS, which could induce a greater compliance with a medical prescription, and promote adaptive coping strategies (MesserliBürgy et al., 2015) and healthy behaviors (Benyamini, Roziner, Goldbourt, Drory, & Gerber, 2013; Gale et al., 2017) . Alternatively, an incident depressive episode could limit those healthy behaviors, and the concomitant higher levels of anxiety might even bolster its cardiotoxic effect through an adrenergic stimulation .
The strict inclusion criteria (i.e., no history of or current depressive disorder and patients experiencing their first ACS) and the long follow-up period resulted in a relatively small number of subjects who developed a depressive disorder and recurrent MACE. This could have resulted in the nonsignificant effect of anxiety on recurrent MACE in this group. It is possible that although all the MACEs occurred after the depressive episodes, our results could underestimate the real interaction of depression and anxiety on cardiac outcome, as depressive episodes with an This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
onset in the second year may not have yet exerted their whole cardiotoxic effect. By adopting the AUC as a method to assess the dose-response effect, we may have lost the suggested dichotomization in transient and persistent depressive symptoms . Similarly, the inclusion of only those with no previous or current depressive episodes does not allow a direct comparison between first-time and recurrent depression (Carney & Freedland, 2012) .
A possible limitation was excluding the subjects who dropped out from the survival analysis. When considering those who completed the questionnaires at baseline but dropped out during the follow-up (n ϭ 38) as censored, results were substantially overlapping. The best predictor was still developing an incident depressive 
Conclusion
Our results confirm the well-established detrimental effect of incident depression on cardiac prognosis (Frasure-Smith & Lespérance, 2008; Yammine et al., 2017) . We suggest that clinicians should both keep in mind the possible risk factors for its development (Ossola, Paglia, et al., 2015) and, given the associated burden (Szpakowski, Qiu, Masih, Kurdyak, & Wijeysundera, 2017) , treat the disorder (Gerra et al., 2014; Mavrides & Nemeroff, 2013; Smolderen, Buchanan, et al., 2017) and related conditions (Carney, Freedland, Steinmeyer, Rubin, & Rich, 2016) . Further, the present study proposes that anxious symptoms immediately after the first cardiac event could be an ally in preventing cardiac events in patients who do not develop incident depression.
